CareersInvestor RelationsPress RoomCOVID-19
Login

News from Siemens Healthineers

What makes for an optimized diagnostic experience in the eye of the patient?

Redefining telehealth

 2021-07-28

From remote scanning in diagnostic to telesurgery - there is more to telehealth than virtual consultations. How to drive growth through remote technologies and connect care teams and patients.

Digitalizing healthcare

Precision COVID-19 testing in the vaccine era: Solving challenges for 2021 and beyond

 2021-07-13

Testing continues to be a cornerstone in the pandemic fight. Learn how it can support to overcome current and future challenges.

Expanding precision medicine
What makes for an optimized diagnostic experience in the eye of the patient?

Key factors to optimize the diagnostic experience

 2021-07-13

Sharing the results of an survey with The Beryl Institute this paper describes why optimizing the diagnostic experience is a priority for healthcare leaders.

Improving patient experience
Patient dealing with different challenges in strengthening trust during and beyond the pandemic.

Strengthening patient trust: a priority for healthcare sustainability

 2021-07-01

Discussing different challenges during and after the pandemic this paper shares recommendations for strengthening patient trust.

Improving patient experience
covid19 testing vaccine challenges

How to overcome the challenges of COVID-19 testing in the vaccination era

 2021-04-29

Testing continues to be a cornerstone in the fight against COVID-19. Learn how vaccination requires refined thinking around it.

Contact Us

Siemens Medical Solutions USA, Inc.

40 Liberty Boulevard
Malvern, PA 19355
United States of America

1The Dosimetry Research Tool shown in the image is an Investigational Device. Limited by Federal (or United States) law to investigational use. This device is exclusively for clinical investigations. This Investigational Device does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not commercially available in the European Union, or other countries worldwide.